nonprofit logo

Dana-Farbermass General Brigham Cancer Care Inc

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 043320640 ✦ Boston, MA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Dana-Farbermass General Brigham Cancer Care Inc?

Dana-Farbermass General Brigham Cancer Care Inc is a Boston-based nonprofit organization dedicated to the investigation of new cancer treatments through clinical trials and research. With a mission to find a cure for cancer, the organization coordinates oncology clinical research, education, and programs across Dana-Farber, Massachusetts General Hospital, and Brigham and Women's Hospital.


Official website here: www.cancercare.harvard.edu

What are the reviews and ratings of this charity?

Charity Navigator Rating: 66% (Two-Star out of Four Stars)

Dana-Farber Mass General Brigham Cancer Care Inc has received a Two-Star rating from Charity Navigator, indicating some concerns regarding its governance and financial practices. While the organization excels in its program expense ratio, showing that almost all funds are dedicated to its programs, it struggles with board independence, which can impact accountability.

The charity has no independent board members, which contributes to a lower overall score in the accountability and finance category. However, it maintains strong financial practices that include a well-managed audit and oversight committee, and it has appropriate policies in place for conflict of interest and whistleblowing.

Despite these strengths, the lack of independent board members and transparency in financial documentation, such as a missing tax form on its website, raises questions about governance practices. Overall, while Dana-Farber Mass General Brigham Cancer Care Inc demonstrates a commitment to its mission through effective program spending, improvements in board independence and transparency are necessary for enhancing its credibility.


This AI summary has been generated from information found on Charity Navigator.

Is Dana-Farbermass General Brigham Cancer Care Inc legitimate?

Dana-Farbermass General Brigham Cancer Care Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Dana-Farbermass General Brigham Cancer Care Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $512,032

For more financial information, click here


Official website here: www.cancercare.harvard.edu

What is the mission statement of Dana-Farbermass General Brigham Cancer Care Inc?

Dana-Farbermass General Brigham Cancer Care Inc focuses on coordinating clinical research, education, and programs related to oncology across Dana-Farber, Massachusetts General Hospital, and Brigham and Women's Hospital. Their primary objective is to investigate new medications and methods of cancer treatment through clinical trial studies, with the ultimate goal of finding a cure. They collaborate on research initiatives to advance oncology care and expand the understanding of various cancer types. The organization's efforts contribute significantly to the healthcare community in the mission to eradicate cancer. By pooling resources and expertise, they aim to deliver groundbreaking advancements in cancer care and improve patient outcomes.


Official website here: www.cancercare.harvard.edu

Who is the CEO of Dana-Farbermass General Brigham Cancer Care Inc?

Unavailable


Official website here: www.cancercare.harvard.edu

What is the revenue of Dana-Farbermass General Brigham Cancer Care Inc?

Dana-Farbermass General Brigham Cancer Care Inc's revenue in 2022 was $97,184,276.


Official website here: www.cancercare.harvard.edu

Who are the executives of Dana-Farbermass General Brigham Cancer Care Inc and what are their salaries?


Here are 12 key members and their salaries:


Ramesh A Shivdasani Md Phd (Trustee And President)
  • Compensation: $0
  • Related: $484,168
  • Other: $43,484
Bruce Johnson Md (Trustee)
  • Compensation: $0
  • Related: $671,141
  • Other: $56,584
David P Ryan Md (Trustee)
  • Compensation: $0
  • Related: $942,912
  • Other: $61,870
Jeffrey Meyerhardt Md Phd (Trustee)
  • Compensation: $0
  • Related: $488,567
  • Other: $70,862
Joseph Loscalzo Md Phd (Trustee)
  • Compensation: $0
  • Related: $898,852
  • Other: $66,010
Ravi I Thadhani Md Mph (Trustee)
  • Compensation: $0
  • Related: $1,280,098
  • Other: $63,556
Hillary Mankin-Kufe Esq (Clerk (As Of 3/28/22))
  • Compensation: $0
  • Related: $232,569
  • Other: $17,271
John Ryan Esq (Clerk (End 1/14/22))
  • Compensation: $0
  • Related: $617,744
  • Other: $31,945
Sally Mason Boemer (Treasurer)
  • Compensation: $0
  • Related: $1,519,675
  • Other: $63,679
Edward J Benz Jr Md (Former Officer)
  • Compensation: $0
  • Related: $2,163,654
  • Other: $51,485
Laurie H Glimcher Md (Former Officer)
  • Compensation: $0
  • Related: $3,672,655
  • Other: $321,403
Richard S Boskey Esq (Former Officer)
  • Compensation: $0
  • Related: $799,400
  • Other: $51,348


Official website here: www.cancercare.harvard.edu

Where can I find the form 990 for Dana-Farbermass General Brigham Cancer Care Inc?

Dana-Farbermass General Brigham Cancer Care Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.cancercare.harvard.edu

Learn more at the official website: www.cancercare.harvard.edu

Mission Statement of Dana-Farbermass General Brigham Cancer Care Inc

Dana-Farbermass General Brigham Cancer Care Inc is a dynamic organization dedicated to coordinating oncology clinical research, education, and programs across Dana-Farber, Massachusetts General Hospital, and Brigham and Women's Hospital. In simpler terms, they bring together the collective strengths of these esteemed institutions to investigate new medications and methods of cancer treatment with the ultimate goal of finding a cure.

The mission of Dana-Farbermass General Brigham Cancer Care Inc is multifaceted. It encompasses the exploration of clinical trial studies and research, which plays a pivotal role in advancing the field of oncology. The organization's researchers work tirelessly to uncover new ways to combat cancer, pushing the boundaries of medical knowledge and bringing hope to countless individuals facing this disease.

Moreover, Dana-Farbermass General Brigham Cancer Care Inc is deeply committed to the education of both medical professionals and the general public. They foster an environment of continuous learning, believing that knowledge is a powerful tool in the fight against cancer. Through their collaborative efforts, they are able to share their discoveries and insights with the wider community, contributing to the advancement of cancer care and ultimately, improving patient outcomes.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Dana-Farbermass General Brigham Cancer Care Inc significantly impacts the landscape of oncology through its dedicated coordination of clinical research, education, and programs among three prominent institutions: Dana-Farber, Massachusetts General Hospital, and Brigham and Women’s Hospital. By streamlining efforts in clinical trial studies, this organization fosters innovative research aimed at exploring new medications and treatment methodologies for cancer. Their commitment to advancing knowledge and therapeutic options in oncology plays a crucial role in the ongoing quest for a cure, ultimately benefiting patients and the broader medical community in Boston and beyond. The collaborative synergy among these institutions enhances the scope and effectiveness of cancer research, positioning them at the forefront of medical advancement and patient care.




This information is meant to be a general summary of Dana-Farbermass General Brigham Cancer Care Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$97,184,276 (2022)
Expenses
$97,787,344 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $61,027
  • Program Service Revenue: $97,123,249
  • Gross Receipts: $97,184,276

Assets and Liabilities:

  • Total Assets: $32,590,487
  • Total Liabilities: $24,571,420
  • Net Assets: $8,019,067

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

CLINICAL TRIALS/RESEARCH

Revenue

$97,123,249

Organization Details

Founding Year

1996

Main Address

450 BROOKLINE AVE BP418, BOSTON, MA, 02215

NTEE Category

Code: H300 - Medical research

If you are a representative of Dana-Farbermass General Brigham Cancer Care Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.